VOLUME
67 2006 NUMBER 4
Original Articles
509 Atypical Antipsychotics in the Treatment of Mania: A Meta-Analysis of
Randomized, Placebo-Controlled Trials. [CME]
Roy H. Perlis, Jeffrey A. Welge, Lana A. Vornik, Robert M. A. Hirschfeld,
and Paul E. Keck, Jr.
[Abstract]
[PDF]
517 Suicide Rates in Relation to Health Care Access in the United States:
An Ecological Study. Leonardo Tondo, Matthew J. Albert, and Ross J.
Baldessarini
[Abstract]
[PDF]
524 Functional Impairments in Adults With Self-Reports of Diagnosed ADHD:
A Controlled Study of 1001 Adults in the Community. Joseph Biederman,
Stephen V. Faraone, Thomas J. Spencer, Eric Mick, Michael C. Monuteaux, and
Megan Aleardi
[Abstract]
[PDF]
541 Neurologic Soft Signs in Borderline Personality Disorder. José
Manuel De la Fuente, Julio Bobes, Coro Vizuete, Maria-Teresa Bascaran,
Ignacio Morlán, and Julien Mendlewicz
[Abstract]
[PDF]
547 Weight Management Program for Treatment-Emergent Weight Gain in
Olanzapine-Treated Patients With Schizophrenia or Schizoaffective Disorder:
A 12-Week Randomized Controlled Clinical Trial. Jun Soo Kwon, Jung-Seok
Choi, Won-Myoung Bahk, Chang Yoon Kim, Chan Hyung Kim, Young Chul Shin,
Byung-Joo Park, and Chang Geun Oh
[Abstract]
[PDF]
554 A Systematic Review of Modafinil: Potential Clinical Uses and
Mechanisms of Action. Jacob S. Ballon and David Feifel
[Abstract]
[PDF]
567 Characterizing Impaired Driving in Adults With
Attention-Deficit/Hyperactivity Disorder: A Controlled Study. Ronna
Fried, Carter R. Petty, Craig B. Surman, Bryan Reimer, Megan Aleardi,
Jessica M. Martin, Joseph F. Coughlin, and Joseph Biederman
[Abstract]
[PDF]
575 Metabolic Syndrome and the Risk of Coronary Heart Disease in 367
Patients Treated With Second-Generation Antipsychotic Drugs. Christoph U.
Correll, Anne M. Frederickson, John M. Kane, and Peter Manu
[Abstract]
[PDF]
584 Differences in Axis I and II Comorbidity Between Bipolar I and II
Disorders and Major Depressive Disorder. Outi Mantere, Tarja K. Melartin,
Kirsi Suominen, Heikki J. Rytsälä, Hanna M. Valtonen, Petri Arvilommi, Sami
Leppämäki, and Erkki T. Isometsä
[Abstract]
[PDF]
594 Psychiatric Comorbidity in Binge-Eating Disorder as a Function of
Smoking History. [CME]
Marney A.
White and Carlos M. Grilo
[Abstract]
[PDF]
600 Serotonin-Norepinephrine Reuptake Inhibitors in the Treatment of
Obsessive-Compulsive Disorder: A Critical Review. Bernardo Dell'Osso,
Gerald Nestadt, Andrea Allen, and Eric Hollander
[Abstract]
[PDF]
611 A Randomized Double-Blind Trial of Paroxetine and/or
Dextroamphetamine and Problem-Focused Therapy for
Attention-Deficit/Hyperactivity Disorder in Adults. Margaret Weiss, Lily
Hechtman, and The Adult ADHD Research Group
[Abstract]
[PDF]
620 Moral Objections to Suicide: Can They Counteract Suicidality in
Patients With Cluster B Psychopathology? Kanita Dervic, Maria A. Oquendo,
Dianne Currier, Michael F. Grunebaum, Ainsley K. Burke, and J. John Mann
[Abstract]
[PDF]
626 A Randomized, Double-Blind, Placebo-Controlled 26-Week Trial of
Aripiprazole in Recently Manic Patients With Bipolar I Disorder. Paul E.
Keck, Jr., Joseph R. Calabrese, Robert D. McQuade, William H. Carson, Berit
X. Carlson, Linda M. Rollin, Ronald N. Marcus, and Raymond Sanchez, for the
Aripiprazole Study Group
[Abstract]
[PDF]
638 Efficacy of Ziprasidone Against Hostility in Schizophrenia: Post Hoc
Analysis of Randomized, Open-Label Study Data. Leslie Citrome, Jan
Volavka, Pal Czobor, Shlomo Brook, Antony Loebel, and Francine S. Mandel
[Abstract]
[PDF]
643 Factors Associated With Temporal Priority in Comorbid Bipolar I
Disorder and Alcohol Use Disorders: Results From the National Epidemiologic
Survey on Alcohol and Related Conditions. Benjamin I. Goldstein and
Anthony J. Levitt
[Abstract]
[PDF]
Focus on Alzheimer's Disease and Related Disorders
650 In This Issue: The Genetic, Transcriptomic, and Proteomic Study of
Alzheimer's Disease. Eric M. Reiman
[PDF]
652 Genetics, Transcriptomics, and Proteomics of Alzheimer's Disease.
Andreas Papassotiropoulos, Michael Fountoulakis, Travis Dunckley, Dietrich
A. Stephan, and Eric M. Reiman
[Abstract]
[PDF]
ASCP Corner
671 Novel Transdermal Delivery Formulation of the Monoamine Oxidase
Inhibitor Selegiline Nearing Release for Treatment of Depression. Michael
E. Thase
[PDF]
Letters To the Editor
673 Simultaneous True Seizures and Pseudoseizures. Chittaranjan Andrade, Nagendra M. Singh, and Savita G. Bhakta
[PDF]
673 The Emergence of Darkness Phobia in a Bipolar Patient During
Quetiapine Treatment. Maria Teresa Plana, Anna Mane, Antoni Benabarre, Jose M. Goikolea, and
Eduard Vieta
[PDF]
674 High-Dose Aripiprazole in Treatment-Resistant Schizophrenia. Harpeet S. Duggal and Dattatreya N. Mendhekar
[PDF]
675 Clozapine Augmentation With Aripiprazole for Negative Symptoms. Laura A. Clarke, Jean-Pierre Lindenmayer, and Saurabh Kaushik
[PDF]
677 Early Bicarbonate Loading and Dantroline for Ziprasidone/Haloperidol-Induced
Neuroleptic Malignant Syndrome. Jeffrey R. Strawn and Paul E. Keck, Jr.
[PDF]
Book Reviews 678